What new weight loss drugs are coming in 2026?

In 2026, new GLP-1 pills like the Wegovy pill and Eli Lilly's upcoming pill will become available, alongside a potentially stronger injection called retatrutide.

Will weight loss drugs be cheaper in 2026?

Yes, new oral GLP-1 medications are expected to be cheaper than current injections, with cash prices starting around $149 for a month's supply.

Is Eli Lilly's retatrutide approved?

Eli Lilly is completing clinical trials for retatrutide and may file for FDA approval as early as this year, with completion of trials expected in 2026.

Home / Health / Weight Loss Pills Arrive: Cheaper, Easier Access in 2026

Weight Loss Pills Arrive: Cheaper, Easier Access in 2026

2 Jan

•

Summary

Weight loss pills are becoming available, offering an alternative to injections.
New GLP-1 drugs promise lower prices and improved accessibility starting in 2026.
A new injection targets three hormones, potentially offering greater weight loss.

Weight Loss Pills Arrive: Cheaper, Easier Access in 2026

The year 2026 marks a significant evolution in weight loss treatments, with the introduction of oral GLP-1 pills and potentially more potent injectable medications. Novo Nordisk's Wegovy pill, approved recently, is expected to become widely available this month, offering an alternative for those averse to needles. Eli Lilly also has a GLP-1 pill anticipated later this year, with hopes that increased market competition will drive down prices.

This shift promises greater affordability and accessibility. The Wegovy pill's cash price is projected to be lower than its injectable counterpart, with potential out-of-pocket costs as low as $25 a month for insured patients. However, adherence to the pill's strict daily schedule is crucial for optimal results. Meanwhile, Eli Lilly is advancing retatrutide, a powerful injection targeting three hormones, which demonstrated nearly 29% average weight loss in trials, though it may come with more severe side effects.